BETTER THERAPEUTICS Stock Price, News & Analysis
Company Description
BETTER THERAPEUTICS (OTC Link: BTTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $5.5K.
BTTX stock has declined 66.7% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, BETTER THERAPEUTICS reported net income of -$39.8M and diluted earnings per share of $-1.69.
This page provides a comprehensive overview of BTTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BETTER THERAPEUTICS (BTTX) stock last traded at $0.0001. Over the past 12 months, the stock has lost 66.7%. At a market capitalization of $5.5K, BTTX is classified as a micro-cap stock with approximately 49.9M shares outstanding.
Latest News
BETTER THERAPEUTICS has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include partnership, fda approval. View all BTTX news →
SEC Filings
Financial Highlights
operating income reached -$38.3M, and net income was -$39.8M. Diluted earnings per share stood at $-1.69. The company generated -$28.9M in operating cash flow. With a current ratio of 1.37, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in BETTER THERAPEUTICS (BTTX) currently stands at 1.0 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BETTER THERAPEUTICS (BTTX) currently stands at 1.4 days, up 39% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 39% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 23.0 days.
BTTX Company Profile & Sector Positioning
BETTER THERAPEUTICS (BTTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BTTX often look at related companies in the same sector, including Novaccess Global Inc (XSNX), Statera Biopharma Inc (STAB), Renovacare (RCAR), Comera Life (CMRA), and Ampio Pharma (AMPE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BTTX's relative position within its industry.